AI Analysis
AI-generated analysis. Always verify with the original filing.
Novo Nordisk A/S filed its updated Articles of Association, detailing share capital structure, governance framework, and board authorizations. The document specifies DKK 446,500,000 in share capital and authorizes the Board to increase capital by up to DKK 44,650,000 until April 1, 2028.
Key Takeaways
1Share capital totals DKK 446,500,000, divided into A shares (DKK 107,487,200) and B shares (DKK 339,012,800).
2Class A shares carry 10 votes per DKK 0.01 nominal value, while Class B shares carry 1 vote per DKK 0.01.
3Board is authorized to increase share capital by up to DKK 44,650,000 until April 1, 2028.
4A shares are non-negotiable instruments; B shares are negotiable instruments.
5Annual General Meetings must be held before the end of April each year.
6The Board of Directors shall consist of 4 to 10 members elected by the General Meeting.